743 related articles for article (PubMed ID: 31037133)
1. Exosomes from M1-Polarized Macrophages Enhance Paclitaxel Antitumor Activity by Activating Macrophages-Mediated Inflammation.
Wang P; Wang H; Huang Q; Peng C; Yao L; Chen H; Qiu Z; Wu Y; Wang L; Chen W
Theranostics; 2019; 9(6):1714-1727. PubMed ID: 31037133
[No Abstract] [Full Text] [Related]
2. Natural killer cell-derived exosome-entrapped paclitaxel can enhance its anti-tumor effect.
Han D; Wang K; Zhang T; Gao GC; Xu H
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5703-5713. PubMed ID: 32495906
[TBL] [Abstract][Full Text] [Related]
3. Exosomes derived from M1 macrophages inhibit the proliferation of the A549 and H1299 lung cancer cell lines via the miRNA-let-7b-5p-GNG5 axis.
Peng J; Li S; Li B; Hu W; Ding C
PeerJ; 2023; 11():e14608. PubMed ID: 36643646
[TBL] [Abstract][Full Text] [Related]
4. Stereocomplex micelle loaded with paclitaxel for enhanced therapy of breast cancer in an orthotopic mouse model.
Piao L; Li Y; Zhang H; Jiang J
J Biomater Sci Polym Ed; 2019 Feb; 30(3):233-246. PubMed ID: 30606090
[TBL] [Abstract][Full Text] [Related]
5. Berberine-loaded M2 macrophage-derived exosomes for spinal cord injury therapy.
Gao ZS; Zhang CJ; Xia N; Tian H; Li DY; Lin JQ; Mei XF; Wu C
Acta Biomater; 2021 May; 126():211-223. PubMed ID: 33722788
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-reoxygenation induces macrophage polarization and causes the release of exosomal miR-29a to mediate cardiomyocyte pyroptosis.
Wang Y; Qiu Z; Yuan J; Li C; Zhao R; Liu W; Deng W; Gu N; Zhang W; Hu S; Bai Z; Shi B
In Vitro Cell Dev Biol Anim; 2021 Jan; 57(1):30-41. PubMed ID: 33420578
[TBL] [Abstract][Full Text] [Related]
7. M1 macrophage-derived exosomes impair beta cell insulin secretion via miR-212-5p by targeting SIRT2 and inhibiting Akt/GSK-3β/β-catenin pathway in mice.
Qian B; Yang Y; Tang N; Wang J; Sun P; Yang N; Chen F; Wu T; Sun T; Li Y; Chang X; Zhu Y; Zhang Y; Han X
Diabetologia; 2021 Sep; 64(9):2037-2051. PubMed ID: 34117507
[TBL] [Abstract][Full Text] [Related]
8. M1 macrophage-derived exosome-encapsulated cisplatin can enhance its anti-lung cancer effect.
Li J; Li N; Wang J
Minerva Med; 2023 Oct; 114(5):634-641. PubMed ID: 32272830
[TBL] [Abstract][Full Text] [Related]
9. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
[TBL] [Abstract][Full Text] [Related]
10. Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells.
Saari H; Lázaro-Ibáñez E; Viitala T; Vuorimaa-Laukkanen E; Siljander P; Yliperttula M
J Control Release; 2015 Dec; 220(Pt B):727-37. PubMed ID: 26390807
[TBL] [Abstract][Full Text] [Related]
11. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells.
Kim MS; Haney MJ; Zhao Y; Mahajan V; Deygen I; Klyachko NL; Inskoe E; Piroyan A; Sokolsky M; Okolie O; Hingtgen SD; Kabanov AV; Batrakova EV
Nanomedicine; 2016 Apr; 12(3):655-664. PubMed ID: 26586551
[TBL] [Abstract][Full Text] [Related]
12. Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarization.
Jang JY; Lee JK; Jeon YK; Kim CW
BMC Cancer; 2013 Sep; 13():421. PubMed ID: 24044575
[TBL] [Abstract][Full Text] [Related]
13. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.
Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A
Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785
[TBL] [Abstract][Full Text] [Related]
14. Exosomes from M1-Polarized Macrophages Potentiate the Cancer Vaccine by Creating a Pro-inflammatory Microenvironment in the Lymph Node.
Cheng L; Wang Y; Huang L
Mol Ther; 2017 Jul; 25(7):1665-1675. PubMed ID: 28284981
[TBL] [Abstract][Full Text] [Related]
15. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
16. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
17. Paclitaxel incorporated exosomes derived from glioblastoma cells: comparative study of two loading techniques.
Salarpour S; Forootanfar H; Pournamdari M; Ahmadi-Zeidabadi M; Esmaeeli M; Pardakhty A
Daru; 2019 Dec; 27(2):533-539. PubMed ID: 31317441
[TBL] [Abstract][Full Text] [Related]
18. Bone Marrow Stromal Cell-Derived Exosomes Promote Muscle Healing Following Contusion Through Macrophage Polarization.
Luo Z; Lin J; Sun Y; Wang C; Chen J
Stem Cells Dev; 2021 Feb; 30(3):135-148. PubMed ID: 33323007
[TBL] [Abstract][Full Text] [Related]
19. JD enhances the anti-tumour effects of low-dose paclitaxel on gastric cancer MKN45 cells both in vitro and in vivo.
Wang C; Wang R; Zhou K; Wang S; Wang J; Shi H; Dou Y; Yang D; Chang L; Shi X; Liu Y; Xu X; Zhang X; Ke Y; Liu H
Cancer Chemother Pharmacol; 2016 Nov; 78(5):971-982. PubMed ID: 27620208
[TBL] [Abstract][Full Text] [Related]
20. Hypoxic Tumor-Derived Exosomes Induce M2 Macrophage Polarization via PKM2/AMPK to Promote Lung Cancer Progression.
Zhou S; Lan Y; Li Y; Li Z; Pu J; Wei L
Cell Transplant; 2022; 31():9636897221106998. PubMed ID: 35818293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
